Cyclerion Therapeutics, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | — | $-0.41 | — | Miss |
| Q12026 FY2026 | $-17.20 | $-0.76 | +95.6% | Beat |
| Q42025 FY2025 | $-0.38 | $-0.19 | +50.0% | Beat |
| Q12026 FY2026 | $-0.38 | — | — | Miss |
Back to CYCN overview · CYCN holders · CYCN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.